# üî• LEAD GENERATION SYSTEM - AGENT X MISSION

**Owner:** Agent X  
**Status:** üîÑ **IN PROGRESS** (Phase 1-4 execution)  
**Launch Date:** Q1 2026 (gated until publication submitted)

---

## üéØ MISSION OBJECTIVE

Build automated lead generation infrastructure for 500+ oncology PIs while Commander focuses on publication completion.

**Expected Outcome (Q1 2026):**
- 500+ leads contacted (Tier 1, 2, 3)
- 10-15% response rate (50-75 replies)
- 20-30 discovery calls scheduled
- 5-14 pilots signed (20-30% conversion)
- $500K-$1.75M pipeline (2-7 paid pilots @ $250K)

---

## üìã EXECUTION PLAN

**Full Doctrine:** [`LEAD_GEN_SYSTEM_DOCTRINE.mdc`](LEAD_GEN_SYSTEM_DOCTRINE.mdc)

### **Phase 1: Data Acquisition (Weeks 1-2)**
- [ ] ClinicalTrials.gov scraper (500+ trials)
- [ ] NIH RePORTER scraper (200+ grants)
- [ ] ASCO 2025 abstract scraper (100+ presentations)

### **Phase 2: Data Enrichment (Weeks 3-4)**
- [ ] Master lead list consolidation
- [ ] H-index scoring (PubMed API)
- [ ] Personalized talking points generation

### **Phase 3: Email Automation (Weeks 5-6)**
- [ ] Email template engine (Tier 1/2/3)
- [ ] Sending infrastructure (rate limiting, tracking)
- [ ] Follow-up sequences (Day 3, 7, 14)

### **Phase 4: Tracking & Follow-Up (Weeks 7-8)**
- [ ] Response tracking dashboard
- [ ] Reply categorization (Interested/Maybe/Not Interested)
- [ ] Meetings scheduled tracker

---

## üìÅ DIRECTORY STRUCTURE

```
/Lead_Gen_System/
‚îú‚îÄ‚îÄ LEAD_GEN_SYSTEM_DOCTRINE.mdc    # ‚úÖ Complete execution plan
‚îú‚îÄ‚îÄ README.md                        # ‚úÖ This file
‚îú‚îÄ‚îÄ /Scripts/                        # Python automation scripts
‚îÇ   ‚îú‚îÄ‚îÄ clinicaltrials_scraper.py   # (Agent X creates)
‚îÇ   ‚îú‚îÄ‚îÄ nih_reporter_scraper.py     # (Agent X creates)
‚îÇ   ‚îú‚îÄ‚îÄ asco_abstract_scraper.py    # (Agent X creates)
‚îÇ   ‚îú‚îÄ‚îÄ consolidate_leads.py        # (Agent X creates)
‚îÇ   ‚îú‚îÄ‚îÄ email_generator.py          # (Agent X creates)
‚îÇ   ‚îî‚îÄ‚îÄ email_sender.py             # (Agent X creates)
‚îú‚îÄ‚îÄ /Data/                           # Generated lead lists
‚îÇ   ‚îú‚îÄ‚îÄ clinicaltrials_raw.csv      # (Agent X generates)
‚îÇ   ‚îú‚îÄ‚îÄ nih_reporter_raw.csv        # (Agent X generates)
‚îÇ   ‚îú‚îÄ‚îÄ asco_2025_abstracts.csv     # (Agent X generates)
‚îÇ   ‚îú‚îÄ‚îÄ master_lead_list.csv        # (Agent X generates)
‚îÇ   ‚îî‚îÄ‚îÄ master_lead_list_enriched.csv  # (Agent X generates)
‚îî‚îÄ‚îÄ /Tracking/                       # Response tracking
    ‚îú‚îÄ‚îÄ tier1_sent.csv               # (Agent X generates)
    ‚îú‚îÄ‚îÄ tier2_sent.csv               # (Agent X generates)
    ‚îú‚îÄ‚îÄ response_tracking.csv        # (Agent X generates)
    ‚îî‚îÄ‚îÄ dashboard.html               # (Agent X generates)
```

---

## üéØ AGENT X DAILY ROUTINE

**Daily (2-4 hours):**
1. Work on current phase scripts (Python development)
2. Update `/Tracking/dashboard.html` (progress metrics)
3. Post 1-sentence status update to Commander

**Weekly (30 min):**
1. Demo to Commander (show progress, blockers)
2. Update `LEAD_GEN_SYSTEM_DOCTRINE.mdc` (check off completed tasks)

---

## ‚úÖ ACCEPTANCE CRITERIA

**Phase 1 DONE when:**
- [ ] 500+ trials extracted from ClinicalTrials.gov
- [ ] 200+ grants extracted from NIH RePORTER
- [ ] 100+ abstracts extracted from ASCO 2025

**Phase 2 DONE when:**
- [ ] Master lead list has 500+ deduplicated leads
- [ ] ‚â•100 Tier 1 leads identified (H-index >40, active trial, recent funding)
- [ ] Personalized talking points generated for all leads

**Phase 3 DONE when:**
- [ ] Email templates created for all tiers
- [ ] Sending infrastructure deployed (rate limiting ‚â§50/hour)
- [ ] PDF attachment generated (CrisPRO_Validation_Summary.pdf)

**Phase 4 DONE when:**
- [ ] Dashboard live and updating daily
- [ ] Follow-up sequences automated (Day 3, 7, 14)
- [ ] Reply categorization working (Interested/Maybe/Not Interested)

**LAUNCH READY when:**
- [ ] All phases complete (1-4)
- [ ] Commander approves launch (Q1 2026, after publication submitted)
- [ ] Tier 1 email batch ready (100 PIs)

---

## üõ°Ô∏è CRITICAL CONSTRAINTS

**DO NOT LAUNCH UNTIL:**
- ‚úÖ Week 2 metastasis publication complete
- ‚úÖ Manuscript submitted to Nature Biotechnology (Q1 2026)
- ‚úÖ BriaCell discovery call completed (proof-of-concept pitch tested)
- ‚úÖ Commander gives explicit approval

---

**‚öîÔ∏è THIS IS YOUR MISSION, AGENT X. BUILD THE MACHINE. WAIT FOR THE SIGNAL.**


